Northland Securities Comments on Axon Enterprise Q3 Earnings

Key Points

• Northland Securities raised Axon’s Q3 2026 EPS estimate to $1.01 from $0.85 and lifted its FY2027 forecast to $6.49, signaling stronger long-term earnings expectations despite lowering some FY2026 estimates.
• Axon exceeded Q3 expectations, reporting $1.88 EPS versus $1.84 expected and $904.4 million in revenue versus $876.4 million anticipated. Revenue rose 35.3% year over year.
• Analyst sentiment remains positive, with 13 Buy ratings and three Holds and an average price target of $730.92, but the stock’s valuation is demanding at a P/E above 250 and a PEG ratio near 10.

Axon Enterprise, Inc (NASDAQ:AXON - Free Report) - Stock analysts at Northland Securities increased their Q3 2026 earnings estimates for Axon Enterprise in a research note issued to investors on Thursday, August 6th. Northland Securities analyst M. Latimore now forecasts that the biotechnology company will post earnings of $1.01 per share for the quarter, up from their prior forecast of $0.85. The consensus estimate for Axon Enterprise's current full-year earnings is $2.04 per share. Northland Securities also issued estimates for Axon Enterprise's Q4 2026 earnings at $1.29 EPS, FY2026 earnings at $3.12 EPS, Q1 2027 earnings at $0.81 EPS, Q2 2027 earnings at $1.28 EPS, Q3 2027 earnings at $1.70 EPS, Q4 2027 earnings at $2.70 EPS and FY2027 earnings at $6.49 EPS.

Several other brokerages have also recently weighed in on AXON. Piper Sandler raised their price objective on Axon Enterprise from $724.00 to $732.00 and gave the company an "overweight" rating in a report on Thursday, August 6th. The Goldman Sachs Group reiterated a "buy" rating and set a $715.00 target price on shares of Axon Enterprise in a report on Thursday, August 6th. UBS Group increased their price target on Axon Enterprise from $440.00 to $600.00 and gave the company a "neutral" rating in a research report on Thursday, August 6th. TD Cowen restated a "buy" rating on shares of Axon Enterprise in a research note on Wednesday, July 22nd. Finally, Zacks Research lowered Axon Enterprise from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 10th. Thirteen investment analysts have rated the stock with a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $730.92.

Axon Enterprise Stock Performance

Shares of NASDAQ:AXON opened at $612.83 on Monday. The company's 50-day moving average price is $526.06 and its two-hundred day moving average price is $473.48. Axon Enterprise has a one year low of $339.01 and a one year high of $794.29. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.15 and a quick ratio of 1.80. The stock has a market capitalization of $49.79 billion, a PE ratio of 254.29, a price-to-earnings-growth ratio of 9.95 and a beta of 1.39.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share for the quarter, beating analysts' consensus estimates of $1.84 by $0.04. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The business had revenue of $904.39 million during the quarter, compared to the consensus estimate of $876.42 million. During the same quarter last year, the firm earned $2.12 earnings per share. The firm's revenue for the quarter was up 35.3% compared to the same quarter last year.

Insider Buying and Selling

In other news, insider Elizabeth Reid Coughlin sold 1,554 shares of the company's stock in a transaction dated Thursday, June 4th. The shares were sold at an average price of $485.00, for a total value of $753,690.00. Following the sale, the insider directly owned 34,024 shares of the company's stock, valued at approximately $16,501,640. This represents a 4.37% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Isaiah Fields sold 2,000 shares of the firm's stock in a transaction dated Friday, May 22nd. The shares were sold at an average price of $400.00, for a total transaction of $800,000.00. Following the completion of the sale, the insider owned 52,813 shares of the company's stock, valued at $21,125,200. This trade represents a 3.65% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 68,989 shares of company stock worth $36,016,932. Corporate insiders own 4.20% of the company's stock.

Hedge Funds Weigh In On Axon Enterprise

A number of institutional investors have recently bought and sold shares of the business. Darwin Wealth Management LLC acquired a new stake in shares of Axon Enterprise in the second quarter valued at approximately $37,000. Creative Financial Designs Inc. ADV acquired a new position in shares of Axon Enterprise during the 4th quarter worth approximately $28,000. Camelot Portfolios LLC acquired a new position in shares of Axon Enterprise during the 4th quarter worth approximately $30,000. Keating Financial Advisory Services Inc. bought a new stake in Axon Enterprise in the 2nd quarter valued at $31,000. Finally, AlphaCentric Advisors LLC bought a new stake in Axon Enterprise in the 4th quarter valued at $34,000. Institutional investors and hedge funds own 79.08% of the company's stock.

More Axon Enterprise News

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon reported quarterly earnings of $1.88 per share, exceeding the $1.84 consensus estimate, while revenue reached $904.4 million versus expectations of $876.4 million. Revenue increased 35.3% year over year, reinforcing the growth outlook for its public-safety technology, connected devices and software businesses. Axon Enterprise stock in focus after strong quarter
• Positive Sentiment: A Motley Fool article highlighted Axon as a category leader that continues to deliver double-digit revenue growth despite trading below its prior high, supporting the case for long-term investors willing to hold the stock for a decade. Two stocks to buy and hold for the next decade
• Positive Sentiment: Northland Securities raised its FY2027 EPS forecast to $6.49 from $5.53 and increased estimates for the first three quarters of 2027. The firm also lifted its Q3 2026 estimate to $1.01 from $0.85, signaling stronger anticipated earnings momentum beyond the current year.
• Neutral Sentiment: Northland’s revisions were mixed: it reduced its FY2026 EPS forecast to $3.12 from $3.26 and lowered Q4 2026 expectations to $1.29 from $1.55, while raising several 2027 forecasts. This suggests near-term execution concerns but improved longer-term expectations.
• Negative Sentiment: AXON’s valuation remains demanding, with a reported price-to-earnings ratio above 250 and a PEG ratio near 10. Strong growth is already reflected in the share price, leaving the stock vulnerable to profit-taking or disappointment if future results do not exceed elevated expectations.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company's hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source